{{Rsnum
|rsid=2235306
|Gene=APLN
|Chromosome=X
|position=129650121
|Orientation=plus
|GMAF=0.234
|Gene_s=APLN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 1.8 | 96.3
| HCB | 42.2 | 17.8 | 40.0
| JPT | 36.4 | 18.2 | 45.5
| YRI | 25.4 | 23.8 | 50.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 42.2 | 17.8 | 40.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 2.0 | 98.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20224560
|Title=Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study.
|OA=1
}}
{{PMID Auto
|PMID=19567136
|Title=Association of apelin genetic variants with type 2 diabetes and related clinical features in Chinese Hans.
}}

{{PMID|20125035|OA=1
}} Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}